Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma [NA]

View source ↗

Summary

Clinical trial evaluating the safety and effectiveness of the VisiPlate Aqueous Shunt for refractory open-angle glaucoma. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VisiPlate Aqueous Shunt

Snippet

Sponsor: Avisi Technologies Inc. | Conditions: Open Angle Glaucoma (OAG) | NA | Status: RECRUITING